{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34777683", "DateCompleted": {"Year": "2022", "Month": "02", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "05"}], "Language": ["eng"], "ELocationID": ["3298400", "10.1155/2021/3298400"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model.", "Pagination": {"StartPage": "3298400", "MedlinePgn": "3298400"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is the most common neurodegenerative disease nowadays that causes memory impairments. It is characterized by extracellular aggregates of amyloid-beta (A<i>\u03b2</i>), intracellular aggregates of hyperphosphorylated Tau (p-Tau), and other pathological features. Trilobatin (TLB), a natural flavonoid compound isolated from <i>Lithocarpuspolystachyus</i> Rehd., has emerged as a neuroprotective agent. However, the effects and mechanisms of TLB on Alzheimer's disease (AD) remain unclear. In this research, different doses of TLB were orally introduced to 3\u00d7FAD AD model mice. The pathology, memory performance, and Toll-like receptor 4- (TLR4-) dependent inflammatory pathway protein level were assessed. Here, we show that TLB oral treatment protected 3\u00d7FAD AD model mice against the A<i>\u03b2</i> burden, neuroinflammation, Tau hyperphosphorylation, synaptic degeneration, hippocampal neuronal loss, and memory impairment. The TLR4, a pattern recognition immune receptor, has been implicated in neurodegenerative disease-related neuroinflammation. We found that TLB suppressed glial activation by inhibiting the TLR4-MYD88-NF<i>\u03ba</i>B pathway, which leads to the inflammatory factor TNF-<i>\u03b1</i>, IL-1<i>\u03b2</i>, and IL-6 reduction. Our study shows that TLR4 might be a key target of TLB in AD treatment and suggests a multifaceted target of TLB in halting AD. Taken together, our findings suggest a potential therapeutic effect of TLB in AD treatment."], "CopyrightInformation": "Copyright \u00a9 2021 Jiuyang Ding et al."}, "AuthorList": [{"Identifier": ["0000-0001-9089-1756"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Ding", "ForeName": "Jiuyang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Southern Medical University, Guangzhou 510515, China."}], "LastName": "Huang", "ForeName": "Jian", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Electron Microscopy, School of Basic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Yin", "ForeName": "Dan", "Initials": "D"}, {"Identifier": ["0000-0002-5824-3975"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Key Laboratory of Pharmaceutics of Guizhou Province, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Liu", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Ren", "ForeName": "Zheng", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Good Clinical Practice Center, Affiliated Hospital of Zunyi Medical University, Zunyi 563003, China."}], "LastName": "Hu", "ForeName": "Shanshan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Neurosurgery, Liuzhou People's Hospital, Liuzhou, China."}], "LastName": "Ye", "ForeName": "Yuanliang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Le", "ForeName": "Cuiyun", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zhao", "ForeName": "Na", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Zhou", "ForeName": "Hongmei", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Li", "ForeName": "Zhu", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Qi", "ForeName": "Xiaolan", "Initials": "X"}, {"Identifier": ["0000-0002-6821-3665"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Forensic Medicine, Guizhou Medical University, Guiyang 550004, China."}], "LastName": "Huang", "ForeName": "Jiang", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Polyphenols"}, {"RegistryNumber": "0", "NameOfSubstance": "tau Proteins"}, {"RegistryNumber": "23298I791N", "NameOfSubstance": "trilobatin"}], "MeshHeadingList": [{"QualifierName": ["complications"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["etiology", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Cognitive Dysfunction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["etiology", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Memory Disorders"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Transgenic"}, {"QualifierName": ["etiology", "metabolism", "pathology", "prevention & control"], "DescriptorName": "Neuroinflammatory Diseases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Polyphenols"}, {"QualifierName": ["metabolism"], "DescriptorName": "tau Proteins"}], "CoiStatement": "The authors declare there are no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hoscheidt S., Sanderlin A. H., Baker L. D., et al. Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: a randomized trial. Alzheimer's & Dementia . 2021;17", "ArticleIdList": ["PMC9207984", "34310044"]}, {"Citation": "Alzheimer's A. 2016 Alzheimer's disease facts and figures. Alzheimers Dement . 2016;12(4):459\u2013509.", "ArticleIdList": ["27570871"]}, {"Citation": "Singleton A., Hardy J. The evolution of genetics: Alzheimer's and Parkinson's diseases. Neuron . 2016;90(6):1154\u20131163.", "ArticleIdList": ["PMC4936485", "27311081"]}, {"Citation": "Zolochevska O., Taglialatela G. Selected microRNAs increase synaptic resilience to the damaging binding of the Alzheimer's disease amyloid beta oligomers. Molecular neurobiology . 2020;57(5):2232\u20132243.", "ArticleIdList": ["PMC7170988", "31997075"]}, {"Citation": "Long J. M., Holtzman D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell . 2019;179(2):312\u2013339.", "ArticleIdList": ["PMC6778042", "31564456"]}, {"Citation": "Schott J. M., Aisen P. S., Cummings J. L., Howard R. J., Fox N. C. Unsuccessful trials of therapies for Alzheimer's disease. The Lancet . 2019;393(10166):p. 29.", "ArticleIdList": ["30614456"]}, {"Citation": "Pan R. Y., Ma J., Kong X. X., et al. Sodium rutin ameliorates Alzheimer's disease-like pathology by enhancing microglial amyloid-\u03b2 clearance. Science advances . 2019;5(2, article eaau6328) doi: 10.1126/sciadv.aau6328.", "ArticleIdList": ["10.1126/sciadv.aau6328", "PMC6393001", "30820451"]}, {"Citation": "Jiao S. S., Yao X. Q., Liu Y. H., et al. Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits. Proceedings of the National Academy of Sciences . 2015;112(16):5225\u20135230. doi: 10.1073/pnas.1422998112.", "ArticleIdList": ["10.1073/pnas.1422998112", "PMC4413288", "25847999"]}, {"Citation": "Yang W., Zhou K., Zhou Y., et al. Naringin dihydrochalcone ameliorates cognitive deficits and neuropathology in APP/PS1 transgenic mice. Frontiers in aging neuroscience . 2018;10:p. 169. doi: 10.3389/fnagi.2018.00169.", "ArticleIdList": ["10.3389/fnagi.2018.00169", "PMC5996202", "29922152"]}, {"Citation": "Lee J. H., Ahn N. H., Choi S. B., Kwon Y., Yang S. H. Natural products targeting amyloid beta in Alzheimer's disease. International Journal of Molecular Sciences . 2021;22(5):p. 2341.", "ArticleIdList": ["PMC7956407", "33652858"]}, {"Citation": "Rajasekhar K., Samanta S., Bagoband V., Murugan N. A., Govindaraju T. Antioxidant berberine-derivative inhibits multifaceted amyloid toxicity. iScience . 2020;23(4):p. 101005.", "ArticleIdList": ["PMC7138924", "32272441"]}, {"Citation": "Samanta S., Rajasekhar K., Ramesh M., et al. Naphthalene Monoimide Derivative Ameliorates Amyloid Burden and Cognitive Decline in a Transgenic Mouse Model of Alzheimer's Disease. Advanced Therapeutics . 2021;4(4, article 2000225) doi: 10.1002/adtp.202000225.", "ArticleIdList": ["10.1002/adtp.202000225"]}, {"Citation": "Wieckowska-Gacek A., Mietelska-Porowska A., Wydrych M., Wojda U. Western diet as a trigger of Alzheimer's disease: from metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing research reviews . 2021;70, article 101397", "ArticleIdList": ["34214643"]}, {"Citation": "Lutshumba J., Nikolajczyk B. S., Bachstetter A. D. Dysregulation of systemic immunity in aging and dementia. Frontiers in Cellular Neuroscience . 2021;15:p. 652111. doi: 10.3389/fncel.2021.652111.", "ArticleIdList": ["10.3389/fncel.2021.652111", "PMC8258160", "34239415"]}, {"Citation": "Lind N. A., Rael V. E., Pestal K., Liu B., Barton G. M. Regulation of the nucleic acid-sensing Toll-like receptors. Nature Reviews Immunology . 2021;21", "ArticleIdList": ["PMC8283745", "34272507"]}, {"Citation": "Kollmann T. R., Levy O., Montgomery R. R., Goriely S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity . 2012;37(5):771\u2013783.", "ArticleIdList": ["PMC3538030", "23159225"]}, {"Citation": "Saleh H. A., Yousef M. H., Abdelnaser A. The anti-inflammatory properties of phytochemicals and their effects on epigenetic mechanisms involved in TLR4/NF-kappaB-mediated inflammation. Frontiers in immunology . 2021;12, article 606069", "ArticleIdList": ["PMC8044831", "33868227"]}, {"Citation": "Kerfoot S. M., Long E. M., Hickey M. J., et al. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. The Journal of Immunology . 2004;173(11):7070\u20137077. doi: 10.4049/jimmunol.173.11.7070.", "ArticleIdList": ["10.4049/jimmunol.173.11.7070", "15557205"]}, {"Citation": "Gambuzza M. E., Sofo V., Salmeri F. M., Soraci L., Marino S., Bramanti P. Toll-like receptors in Alzheimer's disease: a therapeutic perspective. CNS & Neurological Disorders - Drug Targets . 2014;13(9):1542\u20131558. doi: 10.2174/1871527313666140806124850.", "ArticleIdList": ["10.2174/1871527313666140806124850", "25106635"]}, {"Citation": "Doyle S. E., O'Connell R. M., Miranda G. A., et al. Toll-like receptors induce a phagocytic gene program through p38. Journal of Experimental Medicine . 2004;199(1):81\u201390. doi: 10.1084/jem.20031237.", "ArticleIdList": ["10.1084/jem.20031237", "PMC1887723", "14699082"]}, {"Citation": "Rahimifard M., Maqbool F., Moeini-Nodeh S., et al. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Research Reviews . 2017;36:11\u201319. doi: 10.1016/j.arr.2017.02.004.", "ArticleIdList": ["10.1016/j.arr.2017.02.004", "28235660"]}, {"Citation": "Chen R., Wang Z., Zhi Z., Tian J., Zhao Y., Sun J. Targeting the TLR4/NF-\u03baB pathway in \u03b2-amyloid-stimulated microglial cells: A possible mechanism that oxysophoridine exerts anti-oxidative and anti- inflammatory effects in an in vitro model of Alzheimer 's disease. Brain Research Bulletin . 2021;175:150\u2013157. doi: 10.1016/j.brainresbull.2021.07.019.", "ArticleIdList": ["10.1016/j.brainresbull.2021.07.019", "34329731"]}, {"Citation": "Gao J., Chen N., Li N., et al. Neuroprotective effects of trilobatin, a novel naturally occurring Sirt3 agonist from Lithocarpus polystachyus Rehd., mitigate cerebral ischemia/reperfusion injury: involvement of TLR4/NF-kappaB and Nrf2/Keap-1 signaling. Antioxidants & redox signaling . 2020;33(2):117\u2013143.", "ArticleIdList": ["32212827"]}, {"Citation": "Li N., Li X., Shi Y. L., et al. Trilobatin, a component from Lithocarpus polystachyrus Rehd., increases longevity in C. elegans through activating SKN1/SIRT3/DAF16 signaling pathway. Frontiers in Pharmacology . 2021;12, article 655045 doi: 10.3389/fphar.2021.655045.", "ArticleIdList": ["10.3389/fphar.2021.655045", "PMC8082181", "33935768"]}, {"Citation": "Vorhees C. V., Williams M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nature Protocols . 2006;1(2):848\u2013858.", "ArticleIdList": ["PMC2895266", "17406317"]}, {"Citation": "Chen N., Wang J., He Y., et al. Trilobatin protects against A\u03b225\u201335-Induced hippocampal HT22 cells apoptosis through mediating ROS/p38/caspase 3-dependent pathway. Frontiers in pharmacology . 2020;11:p. 584. doi: 10.3389/fphar.2020.00584.", "ArticleIdList": ["10.3389/fphar.2020.00584", "PMC7248209", "32508629"]}, {"Citation": "Mirzaei N., Mota B. C., Birch A. M., et al. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease. British Journal of Pharmacology . 2021;178(3):654\u2013671. doi: 10.1111/bph.15312.", "ArticleIdList": ["10.1111/bph.15312", "33140839"]}, {"Citation": "Dejanovic B., Huntley M. A., de Mazi\u00e8re A., et al. Changes in the synaptic proteome in tauopathy and rescue of Tau-induced synapse loss by C1q antibodies. Neuron . 2018;100(6):1322\u20131336.e7. doi: 10.1016/j.neuron.2018.10.014. e1327.", "ArticleIdList": ["10.1016/j.neuron.2018.10.014", "30392797"]}, {"Citation": "Maiti P., Bowers Z., Bourcier-Schultz A., Morse J., Dunbar G. L. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis. Alzheimer's research & therapy . 2021;13(1):p. 37.", "ArticleIdList": ["PMC7871397", "33557949"]}, {"Citation": "Wisniewski T., Goni F. Immunotherapeutic approaches for Alzheimer's disease. Neuron . 2015;85(6):1162\u20131176.", "ArticleIdList": ["PMC4366618", "25789753"]}, {"Citation": "Glass C. K., Saijo K., Winner B., Marchetto M. C., Gage F. H. Mechanisms underlying inflammation in neurodegeneration. Cell . 2010;140(6):918\u2013934.", "ArticleIdList": ["PMC2873093", "20303880"]}, {"Citation": "Scassellati C., Galoforo A. C., Esposito C., Ciani M., Ricevuti G., Bonvicini C. Promising intervention approaches to potentially resolve neuroinflammation and steroid hormones alterations in Alzheimer's disease and its neuropsychiatric symptoms. Aging and Disease . 2021;12(5):1337\u20131357.", "ArticleIdList": ["PMC8279527", "34341712"]}, {"Citation": "Tremblay M. E., Cookson M. R., Civiero L. Glial phagocytic clearance in Parkinson's disease. Molecular neurodegeneration . 2019;14(1):p. 16.", "ArticleIdList": ["PMC6451240", "30953527"]}, {"Citation": "Fan X., Zhang Y., Dong H., Wang B., Ji H., Liu X. Trilobatin attenuates the LPS-mediated inflammatory response by suppressing the NF-kappaB signaling pathway. Food Chemistry . 2015;166:609\u2013615.", "ArticleIdList": ["25053100"]}, {"Citation": "Cameron B., Tse W., Lamb R., Li X., Lamb B. T., Landreth G. E. Loss of interleukin receptor-associated kinase 4 signaling suppresses amyloid pathology and alters microglial phenotype in a mouse model of Alzheimer's disease. Journal of Neuroscience . 2012;32(43):15112\u201315123.", "ArticleIdList": ["PMC3505880", "23100432"]}, {"Citation": "Yang J., Wise L., Fukuchi K. I. TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in Alzheimer's disease. Frontiers in immunology . 2020;11:p. 724.", "ArticleIdList": ["PMC7190872", "32391019"]}, {"Citation": "Zhao Z., Li F., Ning J., et al. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF- _\u03ba_ B pathway through microbiota-gut-brain axis. Acta pharmaceutica Sinica B . 2021;11(9):2859\u20132879. doi: 10.1016/j.apsb.2021.03.020.", "ArticleIdList": ["10.1016/j.apsb.2021.03.020", "PMC8463266", "34589401"]}, {"Citation": "Kwilasz A. J., Fulgham S. M., Duran-Malle J. C., et al. Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain. Brain, Behavior, and Immunity. . 2021;93:80\u201395.", "ArticleIdList": ["PMC8475740", "33358978"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "8", "Day": "9"}, {"Year": "2021", "Month": "10", "Day": "26"}, {"Year": "2021", "Month": "11", "Day": "15", "Hour": "7", "Minute": "2"}, {"Year": "2021", "Month": "11", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "2", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["34777683", "PMC8589506", "10.1155/2021/3298400"]}}], "PubmedBookArticle": []}